Pharmaceutical and biotechnology company Moderna (MRNA) has filed an application with the U.S. Food and Drug Administration to authorize emergency use of its COVID-19 vaccine in adolescents. On June 8, Moderna submitted a conditional marketing approval (CMA) request to European Medicines Agency (EMA) seeking the same. Moderna CEO Stephane Bancel said, “We are pleased to announce that we have submitted an emergency use authorization request for our COVID-19 vaccine with the FDA for use in adolescents in the United States.” He added, “We are encouraged that the Moderna COVID-19 vaccine was highly effective at preventing COVID-19 and SARS-CoV-2 infection in adolescents.
https://www.tipranks.com/news/moderna-seeks-emergency-use-authorization-for-covid-19-vaccine-in-adolescents
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more Moderna Charts.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more Moderna Charts.